AntriaBio, Inc.(ANTB)- OTCQB
  • Jason Napodano, CFA | Send Message 11 Jun 2015

    Preclinical Data At ADA Supports Development Of AntriaBio's AB101 $ANTB
      Company Description
      AntriaBio is a biopharmaceutical company that develops novel extended release therapies by combining proprietary formulation and manufacturing capabilities with well-known molecules to significantly improve standards of care. AntriaBio's lead product candidate is AB101, an injectable once-weekly... More
      Sector: Healthcare
      Industry: Drug Manufacturers - Other
      Country: United States